
Whitehawk Therapeutics Inc
WHWKHealthcare|Biotechnology|US
$3.13
+0.11 (+3.64%)
Tangible Book / Share
$2.21
Cash / Share
$2.29
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (2)
Feb 2028
Est. completion
P1PROC
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
NCT07470853n=265
Oct 2028
Est. completion
P1Endometrial Cancer
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
NCT07444814n=226
Recent Press Releases
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
Oct 1, 2026 · PRNewsWire
Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
Sep 13, 2026 · PRNewsWire
Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors
Sep 10, 2026 · PRNewsWire
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Sep 2, 2026 · PRNewsWire
SEC Filings (53)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Apr 28, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 12, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 12, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 12, 2026 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Aug 25, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Jun 13, 2025 | 8-K | Material event | DocumentIndex |
| May 15, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 8, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 8, 2025 | 8-K | Material event | DocumentIndex |
| Apr 28, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 28, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 25, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Apr 8, 2025 | EFFECT | DocumentIndex | |
| Mar 31, 2025 | S-3 | Shelf registration | DocumentIndex |
| Mar 31, 2025 | 8-K/A | Material event | DocumentIndex |
| Mar 28, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Mar 28, 2025 | 10-K | Annual report | DocumentIndex |
| Mar 26, 2025 | 8-K | Material event | DocumentIndex |
| Mar 18, 2025 | 8-K | Material event | DocumentIndex |
| Mar 18, 2025 | D | DocumentIndex | |
| Mar 11, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 10, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 6, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 5, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 4, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 4, 2025 | 8-K | Material event | DocumentIndex |
| Feb 24, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 19, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Feb 18, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Feb 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |